Mature Progression-Free Survival in Stage IV Non-Small Cell Lung Cancer Patients Treated With Pemetrexed Maintenance Therapy

被引：0
|
作者：
Bhatt, P. [1 ]
Bonomi, P. [1 ]
Basu, S. [2 ]
Batus, M. [1 ]
机构：
[1] Rush Univ, Med Ctr, Sect Med Oncol, Chicago, IL 60612 USA
[2] Rush Univ, Med Ctr, Chicago, IL 60612 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
PROGRESSION FREE SURVIVAL; non small cell lung cancer; Premetrexed;
D O I：
10.1016/j.jtho.2018.08.1565
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.01-05
引用
收藏
页码：S868 / S869
页数：2
相关论文
共 50 条
  • [21] Therapy of non-small cell lung cancer in stage IV
    Deppermann, Karl-Matthias
    Huber, Rudolf M.
    Laack, Eckart
    Reck, Martin
    Serke, Monika
    von Pawel, Joachim
    ONKOLOGIE, 2006, 29 : 15 - 19
  • [22] Association of baseline plasma D-dimer and platelets with progression-free survival in patients with stage IV non-small cell lung cancer treated with anti-PD-1 antibody
    Pang, Boyue
    Wang, Jing
    Wang, Jing
    Zhang, Jiali
    Ren, Xiubao
    Han, Ying
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (11)
  • [23] Effect of antimicrobial therapy on progression-free survival of patients with non-small cell lung cancer receiving checkpoint inhibitor- and chemotherapy
    Uhlenbruch, Mark
    Kruger, Stefan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (08) : 2079 - 2082
  • [24] Effect of antimicrobial therapy on progression-free survival of patients with non-small cell lung cancer receiving checkpoint inhibitor- and chemotherapy
    Mark Uhlenbruch
    Stefan Krüger
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 2079 - 2082
  • [25] Extending Survival of Stage IV Non-Small Cell Lung Cancer
    Carnio, Simona
    Novello, Silvia
    Mele, Teresa
    Levra, Matteo Giaj
    Scagliotti, Giorgio Vittorio
    SEMINARS IN ONCOLOGY, 2014, 41 (01) : 69 - 92
  • [26] Is survival improving in stage IV non-small cell lung cancer?
    Birnbaum, A. E.
    Ng, T.
    O'Connor, B.
    Plette, A.
    Berz, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [27] Predictive factors for poor progression-free survival in patients with non-small-cell lung cancer treated with nivolumab
    Taniguchi, Y.
    Tamiya, A.
    Isa, S-I.
    Nakahama, K.
    Okishio, K.
    Shiroyama, T.
    Suzuki, H.
    Inoue, T.
    Tamiya, M.
    Nishino, K.
    Kumagai, T.
    Hirashima, T.
    Imamura, F.
    Atagi, S.
    ANNALS OF ONCOLOGY, 2017, 28
  • [28] Maintenance therapy with pemetrexed in non-small-cell lung cancer: Impact on survival
    Vaz, Daniel
    Campainha, Sergio
    Antunes, Ana
    Conde, Sara
    Barroso, Ana
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [29] Germline Variants in Angiogenesis Genes as Markers of Progression-free Survival in Stage I-III Non-small Cell Lung Cancer Patients
    Innocenti, F.
    Owzar, K.
    Jiang, C.
    Crona, D.
    Etheridge, A.
    Jassem, J.
    Rzyman, W.
    Hirsch, F. R.
    Dziadziuszko, R.
    Glubb, D. M.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 150 - 150
  • [30] Two year progression free survival in stage IV NSCLC patients treated with pemetrexed continuation maintenance.
    Macklis, Jason Nathaniel
    Saleem, Fatima
    Esmail, Fatema Mohammed
    Basu, Sanjib
    Fidler, Mary J.
    Bonomi, Philip
    Batus, Marta
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345